Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
This webinar on the Marie Skłodowska-Curie Actions (MSCA) Cofund 2025 call is organised by the National Contact Points (NCPs) for MSCA in Belgium NCP Flanders, NCP-FNRS and NCP Federal BE.
The MSCA Cofund action provides complementary funding for new or existing doctoral programmes or postdoctoral programmes at regional, national and international level. Its aim is to spread the MSCA policies based on the European Charter for Researchers, including international, inter-sectoral and interdisciplinary research training and international and cross-sectoral mobilty of researchers in all stages of their career. The MSCA Cofund 2025 call is expected to open on the 23 January with a deadline on 24 June 2025.
During this webinar the objectives of Cofund, call modalities and hands-on information on the application submission and evaluation process will be provided, complemented by the perspectives from a partner in a MSCA Cofund and an expert evaluator. Furthermore an overview of the services of the Marie Curie Alumni Association (MCAA) will be presented (TBC).
Participation to this webinar is free and open to researchers and staff members willing to apply with a Belgian institution from the academic and non-academic sectors including industry, businesses, SMEs, public administration, civil society organisations, etc. Registration is required. The registration form offers the possibility to write any question for the speakers you might have at this stage.
The registration form is available on the event webpage.
Programme
14.00 Welcome and support services
14.10 Modalities of the MSCA Cofund 2025 call
14.40 Questions and Answers
15.10 Perspectives from a laureate of a Cofund call and Questions and Answers
15.30 Perspectives from an Expert Evaluator and Questions and Answers
15.50 Marie Curie Alumni Association (MCAA) overview of services and Questions and Answers
16.10 Closure of the meeting
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security AI, data & cloud Cybersecurity Defence Space
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.